InspireMD reports Q4 revenue $3.1M (+62% YoY); guides FY2026 rev $13-15M

InspireMD, Inc.

Q4 revenue $3.1M, up 62% YoY; U.S. rev $0.9M (sequential +74%)
Gross margin improved to 37.5% from 24.1% YoY; net loss $11.8M ($0.14/share)
Full year 2025 rev $9.0M (+28% YoY); net loss $48.8M
Cash and securities $54.2M at Dec 31, 2025 vs $34.6M year earlier
FY2026 revenue guidance $13-15M (45-65% growth); PMA-S submitted for TCAR indication

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.